Literature DB >> 7544991

Interleukin-11 induces phosphatidic acid formation and activates MAP kinase in mouse 3T3-L1 cells.

R A Siddiqui1, Y C Yang.   

Abstract

Interleukin-11 (IL-11) stimulated [3H]phosphatidic acid (PA) formation in [3H]arachidonic acid (AA) prelabelled quiescent mouse 3T3-L1 cells. When IL-11 stimulated 3T3-L1 cells were incubated with NaF, a phosphatidic acid phosphohydrolase (PAP) inhibitor, increased PA formation was observed. In the presence of ethanol, phosphatidylethanol accumulated at the expense of PA. These results indicated that the formation of PA upon IL-11 stimulation was a result of phospholipase D (PLD) activation. Endogenous accumulation of PA by NaF treatment or exogenously added PA enhanced tyrosine phosphorylation of two proteins of 44 KDa (p44) and 47 KDa (p47) whereas tyrosine phosphorylation of other proteins was not affected. Among various PA species, dipalmitoyl PA was found to be most effective in enhancing tyrosine phosphorylation of these proteins. p44 and p47 cross reacted with anti-MAP kinase monoclonal antibody (MoAb) in both immunoprecipitation and western blot analysis. Lysates from IL-11-induced or PA-induced cells stimulated phosphorylation of a synthetic peptide substrate for MAP kinase, indicating the activation of MAP kinase in the induced cells. These studies suggest that one of the cellular signalling mechanisms of IL-11 in 3T3-L1 cells involves the activation of phospholipase D to produce the second messenger PA. The increased level of PA enhances tyrosine phosphorylation of p44 and p47 which belong to the members of MAP kinase family and thus transduces some of the mitogenic signals of IL-11 in this cell line.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544991     DOI: 10.1016/0898-6568(94)00083-n

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  5 in total

1.  Synaptic vesicle-like lipidome of human cytomegalovirus virions reveals a role for SNARE machinery in virion egress.

Authors:  Sean T H Liu; Ronit Sharon-Friling; Pavlina Ivanova; Stephen B Milne; David S Myers; Joshua D Rabinowitz; H Alex Brown; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

2.  Characterization and purification of neutrophil ecto-phosphatidic acid phosphohydrolase.

Authors:  D English; M Martin; K A Harvey; L P Akard; R Allen; T S Widlanski; J G Garcia; R A Siddiqui
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

3.  Involvement of lipid mediators on cytokine signaling and induction of secretory phospholipase A2 in immortalized astrocytes (DITNC).

Authors:  W Tong; D Shah; J Xu; J A Diehl; A Hans; M Hannink; G Y Sun
Journal:  J Mol Neurosci       Date:  1999-04       Impact factor: 3.444

4.  Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours.

Authors:  S L Cheeseman; M Brannan; A McGown; P Khan; C Gardner; L Gumbrell; D Dickens; M Ranson
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

5.  Selectivity of mTOR-Phosphatidic Acid Interactions Is Driven by Acyl Chain Structure and Cholesterol.

Authors:  Jolanta Żelasko; Aleksander Czogalla
Journal:  Cells       Date:  2021-12-30       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.